FDA completes safety review of MS drug

The multiple sclerosis drug fingolimod (Gilenya, Novartis) is now contraindicated for use in patients with certain pre-existing or recent heart conditions or stroke, or who are taking certain antiarrhythmic medications, according to FDA. » Full article

FDA committee supports first drug for HIV prevention

FDA’s Antiviral Drugs Advisory Committee has recommended approval of once-daily oral emtricitabine and tenofovir disoproxil fumarate (Truvada, Gilead Sciences) to reduce the risk of HIV-1 infection among uninfected adults, an HIV-prevention strategy called pre-exposure prophylaxis or PrEP. » Full article

CONTINUING EDUCATION

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. » Full article

Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Headline Headline Headline Headline

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip consequat. » More

ACC conference highlights latest in research, practice, technology

The American College of Cardiology's 61st Annual Scientific Session & Expo held in Chicago, provided the latest information in research, practice, and technology in cardiology, including presentations on triple-antiplatelet therapy after percutaneous coronary intervention; an investigational thrombin receptor that cuts the risk of second cardiovascular events; and a human monoclonal antibody that exhibits powerful reductions in LDL cholesterol. » Full article

Survey

With specialty drug products representing the fastest growing component of today’s drug expenditures, which of the following would you rate as the most important service a specialty pharmacy can provide in helping to optimize the quality and cost-efficiency of specialty pharmaceutical care?

a) Waste Management

b) Patient risk assesssment and education

c) Manging prior authorization of specialty products

d) Outcomes monitoring, reporting, and intervention

e) Helping patients navigate financial assistance programs

a) Adherence programs

Click here to see what your colleagues are using too

Click Here. to see the results of our last survey regarding healthcare industry trends and which one will have the most significant impact on the ability to manage pharmacy ependitures over the next 2-5 years

Subscribe Now!

You must click here to continue receiving the Formulary News Capsule

• Drug Watch: Multiple sclerosis

• Coadministration of boceprevir with ritonavir-boosted HIV protease inhibitors could reduce drugs' effectiveness

• Asthma more prevalent among youth with diabetes

RESOURCES

Drug Watch

Latest Clinical News

Editorial Soliciation Section

Copy Here. Send your ideas to julie.miller@advanstar.com

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.